Product description

Therapeutic Area: Cardiovascular system
  • EU DMF available
  • US DMF no. 17060 available
  • CEP available

Indication: Carvedilol is a carbazole derivative acts as anti-hypertensive agent. It is formulated as tablets for oral route of administration. Carvedilol is indicated for the management of essential hypertension. It is also indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction. Is also indicated for the treatment of tachycardiac atrial fibrillation.

Read more

Specifications

Categories Contract Services - Contract ServicesContract Manufacturing
Sales markets Western Europe; Eastern Europe; Middle East; Australia; North America; Africa; Central/South America
Supplied from Poland
Measured In g; Kgs

More products from ZF Polpharma SA

View all our products (32)

Products from other suppliers